The frequency of obesity in patients with acute pancreatitis, chronic pancreatitis and pancreatic cancer

BACKGROUND: In the XXI century, the frequency of pancreas diseases increased 2–3 times. The expectation that causes a pandemic lead to the development of a number of diseases. The results of studies on the relationship of overweight, obesity with the risk of developing pancreas diseases (acute pancreatitis (AP), chronic pancreatitis (CP) and pancreas cancer (PC)) are very heterogeneous (for AP and PC) and not numerous (for CP).

AIMS: to identify the frequency of obesity in AP patients (APр), CP patients (СPр) and PC patients (PCр) and compare these parameters.

MATERIALS AND METHODS: at the observational multicenter clinical cross-sectional uncontrolled case-study 44 APp, 97 CPp and 45 PCp were examined; the groups were comparable by sex/age. Informed consent form for participate in the study was obtained from all patients. The main outcome of the study: the frequency of obesity in APp, CPp; PCp.

RESULTS: The frequency of obesity in APp (13,6%), CPp (24,7%) and PCp (20,0%) did not differ significantly. Among the examined patients, the lowest average BMI (24,2±0,7 kg/m²) was observed in APp (p=0,049). BMI ≥22,5 kg/m² was found to be associated with AP (OR=0,398; 95%CI 0,195–0,812; p=0,011). An inverse relationship was shown between the BMI and “definite” CP (Exp (B)=0,772; 95%CI 0,632–0,942; p=0,011). In men with CP and in CPp alcoholic etiology, weight deficit was observed significantly more often than in women with CP and in CPp biliary etiology, respectively. Earlier (a year before the present survey), obesity was more common in PCp (55,6%) than in APp (13,6%, χ²=3,3; p=0,000) and CPp (25,8%, χ²=12,0; p=0,001). A history of obesity (in our study one year before PC detection) and PC (OR=4,435; 95% CI 2,180–9,025; p=0,000) direct relationship was shown.

CONCLUSIONS: the frequency of obesity in APp, CPp and PCp was similar. The average BMI was higher in APp, than in CPp and PCp. BMI≥22,5 kg/m2 was a protective factor for AP. BMI was inversely associated with “defined” CP. A history of obesity was directly associated with PC.

acute pancreatitis, chronic pancreatitis, pancreatic cancer, obesity

1. Григорьева И.Н. Острый и хронический панкреатит. – Новосибирск: Наука, 2011. [Grigor’eva IN. Ostryy i khronicheskiy pankreatit. Novosibirsk: Nauka; 2011. (In Russ.)]

2. Дедов И.И., Мельниченко Г.А., Шестакова М.В., и др. Национальные клинические рекомендации по лечению морбидного ожирения у взрослых. 3-ий пересмотр (лечение морбидного ожирения у взрослых) // Ожирение и метаболизм. – 2018. – Т. 15. – № 1 – С. 53–70. [Dedov II, Melnichenko GA, Shestakova MV, et al. Russian national clinical recommendations for morbid obesity treatment in adults. 3rd revision (Morbid obesity treatment in adults). Obesity and metabolism. 2018;15(1):53-70. (In Russ.)] DOI:10.14341/OMET2018153-70

3. Григорьева И.Н., Логвиненко Е.В., Веревкин Е.Г., и др. Клинические характеристики, фактическое питание и профилактика желчнокаменной болезни в сочетании с метаболическим синдромом у женщин // Экспериментальная и клиническая гастроэнтерология. – 2019. – № 5. – С. 91–96. [Grigorieva IN, Logvinenko EV, Verevkin EG, et al. Clinical features, nutrition and prevention of gallstone disease in combination with metabolic syndrome in women. Experimental and clinical gastroenterology. 2019;165(5):91-96. (In Russ.)] DOI:10.31146/1682-8658-ecg-165-5-91-96

4. Григорьева И.Н. Гипертриглицеридемический острый панкреатит: прогресс и проблемы // Атеросклероз. – 2017. – Т. 13. – № 1. – С. 41–48. [Grigor’eva IN. Hypertriglyceridemiс acute pancreatitis: progress and problems. Ateroskleroz. 2017;13(1):41-48. (In Russ.)]

5. Navina S, Acharya C, DeLany JP, et al. Lipotoxicity causes multisystem organ failure and exacerbates acute pancreatitis in obesity. Sci Transl Med. 2011;3(107):107ra110. DOI:10.1126/scitranslmed.3002573

6. Deenadayalu VP, Blaut U, Watkins JL, et al. Does obesity confer an increased risk and/or more severe course of post-ERCP pancreatitis: a retrospective, multicenter study. J Clin Gastroenterol. 2008;42(10):1103-1109. DOI:10.1097/MCG.0b013e318159cbd1

7. Mendez-Bailon M, de Miguel Yanes JM, Jimenez-Garcia R, et al. National trends in incidence and outcomes of acute pancreatitis among type 2 diabetics and non-diabetics in Spain (2001–2011). Pancreatology. 2015;15(1):64-70. DOI:10.1016/j.pan.2014.11.004.

8. Acharya C, Cline RA, Jaligama D, et al. Fibrosis reduces severity of acute-on-chronic pancreatitis in humans. Gastroenterology. 2013;145(2):466-475. DOI:10.1053/j.gastro.2013.05.012

9. Дмитриев А.Н. Метаболический синдром: маркеры индивидуальной предрасположенности, диагностика доклинической стадии, обоснование тактики ведения пациентов // Международный эндокринологический журнал. – 2011. – Т. 2. – № 34. – С. 93–102. [Dmitriev AN. Metabolicheskiy sindrom: markery individual’noy predraspolozhennosti, diagnostika doklinicheskoy stadii, obosnovanie taktiki vedeniya patsientov. International journal of endocrinology. 2011;2(34):93-102. (In Russ.)]

10. Larsson SC, Orsini N, Wolk A. Body mass index and pancreatic cancer risk: A meta-analysis of prospective studies. Int J Cancer. 2007;120(9):1993-1998. DOI:10.1002/ijc.22535

11. Lin Y, Kikuchi S, Tamakoshi A, et al. JACC Study Group. Obesity, physical activity and the risk of pancreatic cancer in a large Japanese cohort. Int J Cancer. 2007;120(12):2665-2671. DOI:10.1002/ijc.22614

12. Tsang NM, Pai PC, Chuang CC, et al. Overweight and obesity predict better overall survival rates in cancer patients with distant metastases. Cancer Med. 2016;5(4):665-675. DOI:10.1002/cam4.634

13. Lennon H, Sperrin M, Badrick E, et al. The Obesity Paradox in Cancer: a Review. Curr Oncol Rep. 2016;18(9):56. DOI:10.1007/s11912-016-0539-4

14. World Cancer Research Fund International. Diet, nutrition, physical activity, and breast cancer survivors. 2014

15. Румянцев П.О., Саенко В.А., Румянцева У.В., Чекин С.Ю. Статистические методы анализа в клинической практике. Часть. 2. Анализ выживаемости и многомерная статистика // Проблемы эндокринологии. – 2009. – Т. 55. – № 6. – С 48–56. [Rumyantsev PO, Saenko VA, Rumyantseva UV, Chekin SY. Statistical methods of analysis in clinical practice. Part. 2. Survival analysis and multivariate statistics. Problems of endocrinology. 2009;55(6):48-56. (In Russ.)] DOI:10.14341/probl200955648-56

16. Муромцева Г.А., Концевая А.В., Константинов В.В., и др. Распространенность факторов риска неинфекционных заболеваний в российской популяции в 2012-2013 гг. Результаты исследования ЭССЕ-РФ // Кардиоваскулярная терапия и профилактика. – 2014. – Т.13. - №6. – С.4-11. [Muromtseva GA, Kontsevaya AV, Konstantinov VV, et al. The prevalence of non-infectious diseases risk factors in Russian population in 2012-2013 years. The results of ECVD-RF. Cardiovascular therapy and prevention. 2014;13(6):4-11. (In Russ.)] DOI:10.15829/1728-8800-2014-6-4-11

17. Chen SM, Xiong GS, Wu SM. Is obesity an indicator of complications and mortality in acute pancreatitis? An updated meta-analysis. J Dig Dis. 2012;13(5):244-251. DOI:10.1111/j.1751-2980.2012.00587.x

18. Martínez J, Sánchez-Payá J, Palazón JM, et al. Is obesity a risk factor in acute pancreatitis? A meta-analysis. Pancreatology. 2004;4(1):42-48. DOI:10.1159/000077025

19. Wang SQ, Li SJ, Feng QX. Overweight is an additional prognostic factor in acute pancreatitis: a meta-analysis. Pancreatology. 2011;11(2):92-98. DOI:10.1159/000327688

20. Al-Azzawi HH, Wade TE, Swartz-Basile DA, et al. Acute pancreatitis in obesity: adipokines and dietary fish oil. Dig Dis Sci. 2011;56(8):2318-2325. DOI:10.1007/s10620-011-1626-x

21. Hall TC, Stephenson JS, Jones MJ, et al. Is Abdominal Fat Distribution Measured by Axial CT Imaging an Indicator of Complications and Mortality in Acute Pancreatitis? J Gastrointest Surg. 2015;19(12):2126-2131. DOI:10.1007/s11605-015-2972-3

22. Taguchi M, Kubo T, Yamamoto M, et al. Body mass index influences the outcome of acute pancreatitis: an analysis based on the Japanese administrative database. Pancreas. 2014;43(6):863-866. DOI:10.1097/MPA.0000000000000137

23. Ammann RW, Raimondi S, Maisonneuve P, et al. Is obesity an additional risk factor for alcoholic chronic pancreatitis? Pancreatology. 2010;10(1):47-53. DOI:10.1159/000225921

24. Машарипова Ю.К., Шамсутдинова М.И. Хронический панкреатит: цитокины и клиническое течение // Вестник науки и образования. – 2019. – № 19-3. – С. 49-52. [Masharipova YK, Shamsutdinova MI. Chronic pancreatitis: cytokines and clinical course. Vestnik nauki I obrazovaniya. 2019;(19-3):49-52. (In Russ.)]

25. Olesen SS, Frandsen LK, Poulsen JL, et al. The prevalence of underweight is increased in chronic pancreatitis outpatients and associates with reduced life quality. Nutrition. 2017;43-44:1-7. DOI:10.1016/j.nut.2017.06.019

26. Roberts KM, Golian P, Nahikian-Nelms M, et al. Does the Healthy Eating Index and Mediterranean Diet Score Identify the Nutritional Adequacy of Dietary Patterns in Chronic Pancreatitis? Dig Dis Sci. 2019;64(8):2318-2326. DOI:10.1007/s10620-019-05536-3

27. Гаврилина Н.С., Ильченко Л.Ю., Седова Г.А., и др. Коррекция трофологической недостаточности у больных хроническим панкреатитом // Архивъ внутренней медицины. – 2019. – Т. 9. – № 1. – С. 70–84. [Gavrilina NS, Ilchenko LY, Sedova GA, et al. Correction of trophic insufficiency in patients with chronic pancreatitis. Russian archives of internal medicine. 2019;9(1):70-84. (In Russ.)] DOI:10.20514/2226-6704-2019-9-1-70-80

28. Губергриц Н.Б., Бондаренко О.А. Показатели ультразвуковой гистографии поджелудочной железы в динамике больных с хроническим панкреатитом на фоне ожирения // Гастроентерология. – 2013. – № 2. – С. 64–67. [Gubergrits NB, Bondarenko OA. Indicators of ultrasonic histography of the pancreas in the dynamics of treatment of patients with chronic pancreatitis on the background of obesity. Gastroenterology. 2013;(2):64-67. (In Russ.)]

29. Johansen D, Stocks T, Jonsson H, et al. Metabolic factors and the risk of pancreatic cancer: a prospective analysis of almost 580,000 men and women in the Metabolic Syndrome and Cancer Project. Cancer Epidemiol Biomarkers Prev. 2010;19(9):2307-2317. DOI:10.1158/1055-9965.EPI-10-0234

30. Luo J, Iwasaki M, Inoue M, et al. Body mass index, physical activity and the risk of pancreatic cancer in relation to smoking status and history of diabetes: a large-scale population-based cohort study in Japan--the JPHC study. Cancer Causes Control. 2007;18(6):603-612. DOI:10.1007/s10552-007-9002-z

31. Genkinger JM, Kitahara CM, Bernstein L, et al. Central adiposity, obesity during early adulthood, and pancreatic cancer mortality in a pooled analysis of cohort studies. Ann Oncol. 2015;26(11):2257-2266. DOI:10.1093/annonc/mdv355

32. Shi YQ, Yang J, Du P, et al. Effect of Body Mass Index on Overall Survival of Pancreatic Cancer A Meta-Analysis. Medicine (Baltimore). 2016;95(14):e3305. DOI:10.1097/MD.0000000000003305

33. Majumder K, Gupta A, Arora N, et al. Premorbid Obesity and Mortality in Patients with Pancreatic Cancer: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2016;14(3):355-e32. DOI:10.1016/j.cgh.2015.09.036.

34. World Cancer Research Fund A. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. Washington: American Institute for Cancer Research. 2007.